Infective Endocarditis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: closed (31 August 2020) | Viewed by 3159
Special Issue Editor
Interests: endocarditis; mitral and tricuspid valve disease; coronary artery bypass grafting; dilated cardiomyopathy; heart failure
Special Issue Information
Dear Colleagues,
As many of you already know, the rate of infectious endocarditis (IE) has grown considerably in the last decade. In the United States, it increased from 9.3 per 100,000 population in 1998 to 15 per 100,000 in 2011. Oral, gastrointestinal, and cutaneous bacteria are mainly responsible for IE. Staphylococcus aureus is the leading cause of native and prosthetic valve infection, causing 30–40% of IE. Guidelines for surgical treatment of infective endocarditis suggest a surgical approach in the case of acute complications, such as valve dysfunction resulting in heart failure, which are associated with a higher risk of mortality or major morbidity than if treated with antibiotic therapy alone, or in the case of high-risk for embolization. Timing for surgery remains under debate. Surgical treatment of heart valve and prosthesis infective endocarditis (IE) accounts for 25–50% of cases in active IE and 20–40% in treated IE. The mortality rate is very heterogeneous, ranging from 6 to 36%. With this Special Issue, we hope to encourage submissions that discuss the current state-of-the-art, address ongoing knowledge gaps, and focus on ongoing controversies related to infective endocarditis.
We look forward to receiving your submission.
Dr. Michele Di Mauro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infective endocarditis
- vegetations
- timing of surgery and infective endocarditis
- heart valve disease
- bacteremia
- valve surgery
